---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-189435"
form_type: "8-K"
ticker: "VOR"
cik: "0001817229"
company_name: "Vor Biopharma Inc."
filed_at: "2025-08-27T23:59:59+00:00"
generated_at: "2026-05-17T09:46:03.667603+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Vor Biopharma announces three director resignations, appoints Sarah Reed

## Summary
- Joshua Resnick, Matthew Patterson, and David Lubner resigned from the Board effective Aug 25-26, 2025; no disagreement cited.
- Sarah Reed, General Counsel of RA Capital Management, appointed as independent Class II director effective Aug 27.
- Reed receives standard compensation: $40k cash retainer, option to purchase 60k shares, and annual option grants.
- Appointment was per securities purchase agreement with RA Capital, which holds >5% of VOR voting stock.

## SEC filing metadata
- accession: 0001193125-25-189435
- form_type: 8-K
- ticker: VOR
- cik: 0001817229
- company_name: Vor Biopharma Inc.
- filed_at: 2025-08-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817229/000119312525189435/0001193125-25-189435-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817229/000119312525189435/d939901d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-189435
- JSON: https://secwatch.observer/filing/0001193125-25-189435.json
- Plain text: https://secwatch.observer/filing/0001193125-25-189435.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.